JBM TC4Alternative Names: JBM-TC-4
Latest Information Update: 25 Nov 2014
At a glance
- Originator Joben Bio-Medical
- Class Herbal medicines; Ketones; Lactams; Skin disorder therapies; Spiro compounds
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Radiodermatitis
Most Recent Events
- 01 Nov 2014 Phase-II clinical trials in Radiodermatitis (Treatment and Prevention) in Taiwan (PO)